Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31 3 months ending 2013-09-30 3 months ending 2013-06-30
Revenue 10.61 15.96 14.74 13.01 9.58
Other Revenue, Total - - - - -
Total Revenue 10.61 15.96 14.74 13.01 9.58
Cost of Revenue, Total 1.19 2.45 1.32 2.54 1.21
Gross Profit 9.42 13.51 13.42 10.47 8.37
Selling/General/Admin. Expenses, Total 5.24 5.07 4.42 4.76 4.31
Research & Development 2.69 3.13 2.37 2.41 2.02
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.14 0.20 0.20 0.23 0.52
Other Operating Expenses, Total - - - - -
Total Operating Expense 9.25 10.86 8.31 9.94 8.07
Operating Income 1.36 5.10 6.42 3.07 1.51
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net 0.06 -2.70 -4.10 -0.65 2.74
Income Before Tax 1.24 2.15 2.01 2.02 3.80
Income After Tax 1.29 2.10 1.87 1.97 3.69
Minority Interest 0.30 0.00 - - 0.00
Equity In Affiliates - - - - -
Net Income Before Extra. Items 1.59 2.10 1.87 1.97 3.69
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 1.59 2.10 1.87 1.97 6.09
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 1.59 2.10 1.87 1.97 3.69
Income Available to Common Incl. Extra Items 1.59 2.10 1.87 1.97 6.09
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - 0.00 - - -
Diluted Weighted Average Shares 21.78 21.78 21.29 20.84 20.43
Diluted EPS Excluding Extraordinary Items 0.07 0.10 0.09 0.09 0.18
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.08 0.11 0.10 0.10 0.21